Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 34 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

Although White and non-White participants were both willing to test (∼77%), non-White participants were approximately four times more likely to test only if their results were not shared with their medical provider/insurer. The desire to test outside of medical environments is further supported by the fact that the most common reason for taking the test was peace of mind (78%) rather than facilitating treatment plans, and that a positive test result would be most shared with family (62%) rather than with doctors right away. Older age was also associated with increased willingness to test, while ethnicity and socioeconomic status were not. Historical contexts and marginalization of minoritized groups may also impact willingness to screen for early ADRD risk/detection, which needs to be explored further. Building medical trust may take decades for some populations, thus supporting the need to develop options now for biomarkers or other ADRD-risk screeners that are accessible and appropriate for culturally diverse groups, both within and outside of a medical context.

Key findings

Why it matters

About 77% of both White and non-White participants were willing to test for dementia risk, but non-White participants were approximately four times more likely to test only if results were not shared with their medical provider or insurer. The study is about willingness to be screened, not about treating, curing, or preventing Alzheimer's disease.

Study details

How this study scored 34/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 34 of 100.34 of 100 points earned66 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2024 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.2 citations a year over 4 year(s) since 2024
Impact for its field and year 1 / 6 Cited 0.3× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Sydney Y. Schaefer: h-index 26 (OpenAlex, whole career)
Institution's track record 1 / 3 Arizona State University: institution h-index 987 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 39750458)
Free to read 2 / 2 Free to read
Total 34 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Reed, A. S., Hooyman, A., Lee, N., Fauth, E. B., Love, J., & Schaefer, S. Y. (2024). Factors influencing adults' willingness to be screened for dementia risk. Alzheimer s & Dementia. https://doi.org/10.1002/alz.091041

Vancouver

Reed AS, Hooyman A, Lee N, Fauth EB, Love J, Schaefer SY. Factors influencing adults' willingness to be screened for dementia risk. Alzheimer s & Dementia. 2024. doi:10.1002/alz.091041. PMID: 39750458.

BibTeX

@article{reed2024-39750458,
  author  = {Reed, Alexandra S. and Hooyman, Andrew and Lee, Nicole and Fauth, Elizabeth Braungart and Love, Jill and Schaefer, Sydney Y.},
  title   = {{Factors influencing adults' willingness to be screened for dementia risk}},
  journal = {Alzheimer s \& Dementia},
  year    = {2024},
  doi     = {10.1002/alz.091041},
  pmid    = {39750458},
  url     = {https://doi.org/10.1002/alz.091041}
}

Related studies in Risk factors

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Risk factors

See all studies in Risk factors →